Advertisement
Screener

ADAPTIMMUNE THERAPEUTICS PLC (ADAPY) APIC, Share-based Payment Arrangement, Increase for Cost Recognition

2.8 / 5 stars · 68/120 Roast Me

ADAPTIMMUNE THERAPEUTICS PLC APIC, Share-based Payment Arrangement, Increase for Cost Recognition

ADAPTIMMUNE THERAPEUTICS PLC (ADAPY) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $1.36 million for the 3-month period ending 2025-06-30, per its 10-Q filed 2025-08-13.

Financial Statements › Shareholders' Equity

us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2025-08-13

  • ADAPTIMMUNE THERAPEUTICS PLC apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-30 was $1.36M, a 55.62% decline year-over-year.
  • ADAPTIMMUNE THERAPEUTICS PLC apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-03-31 was $685.00K, a 77.92% decline year-over-year.
  • ADAPTIMMUNE THERAPEUTICS PLC apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2024-09-30 was $3.06M, a 7.11% decline year-over-year.
  • ADAPTIMMUNE THERAPEUTICS PLC apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2024-06-30 was $3.06M, a 34.85% decline year-over-year.
  • ADAPTIMMUNE THERAPEUTICS PLC apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $12.05M, a 5.35% decline from fiscal 2023.
  • ADAPTIMMUNE THERAPEUTICS PLC apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $12.74M, a 30.18% decline from fiscal 2022.
  • ADAPTIMMUNE THERAPEUTICS PLC apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $18.24M, a 11.58% decline from fiscal 2021.
  • ADAPTIMMUNE THERAPEUTICS PLC apic, share-based payment arrangement, increase for cost recognition for fiscal 2021 was $20.63M, a 98.09% increase from fiscal 2020.
Period endAPIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 monthAPIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 monthAPIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 monthAPIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month
2025-06-30$1.36M
10-Q · filed 2025-08-13
$2.04M
derived: sum of 2 quarters · filed 2025-08-13
2025-03-31$685.00K
10-Q · filed 2025-08-13
2024-12-31$12.05M
10-K · filed 2025-03-24
2024-09-30$3.06M
10-Q · filed 2024-11-13
$6.11M
derived: sum of 2 quarters · filed 2025-08-13
$9.21M
derived: sum of 3 quarters · filed 2025-08-13
2024-06-30$3.06M
10-Q · filed 2025-08-13
$6.16M
derived: sum of 2 quarters · filed 2025-08-13
2024-03-31$3.10M
10-Q · filed 2025-08-13
2023-12-31$12.74M
10-K · filed 2025-03-24
2023-09-30$3.29M
10-Q · filed 2024-11-13
$7.98M
derived: sum of 2 quarters · filed 2024-11-13
$9.66M
derived: sum of 3 quarters · filed 2024-11-13
2023-06-30$4.69M
10-Q · filed 2024-11-13
$6.37M
derived: sum of 2 quarters · filed 2024-11-13
2023-03-31$1.68M
10-Q · filed 2024-11-13
2022-12-31$18.24M
10-K · filed 2025-03-24
2022-09-30$3.66M
10-Q · filed 2023-11-08
$8.71M
derived: sum of 2 quarters · filed 2023-11-08
$14.29M
derived: sum of 3 quarters · filed 2023-11-08
2022-06-30$5.04M
10-Q · filed 2023-11-08
$10.63M
derived: sum of 2 quarters · filed 2023-11-08
2022-03-31$5.59M
10-Q · filed 2023-11-08
2021-12-31$20.63M
10-K · filed 2024-03-06
2021-09-30$5.02M
10-Q · filed 2022-11-08
$10.47M
derived: sum of 2 quarters · filed 2022-11-08
$15.80M
derived: sum of 3 quarters · filed 2022-11-08
2021-06-30$5.45M
10-Q · filed 2022-11-08
$10.78M
derived: sum of 2 quarters · filed 2022-11-08
2021-03-31$5.33M
10-Q · filed 2022-11-08
2020-12-31$10.41M
10-K · filed 2023-03-06
2020-09-30$3.28M
10-Q · filed 2021-11-04
$5.90M
derived: sum of 2 quarters · filed 2021-11-04
$7.35M
derived: sum of 3 quarters · filed 2021-11-04
2020-06-30$2.62M
10-Q · filed 2021-11-04
$4.07M
derived: sum of 2 quarters · filed 2021-11-04
2020-03-31$1.45M
10-Q · filed 2021-11-04
2019-12-31$11.05M
10-K · filed 2022-03-14
2019-09-30$1.82M
10-Q · filed 2020-11-05
$5.02M
derived: sum of 2 quarters · filed 2020-11-05
$8.49M
derived: sum of 3 quarters · filed 2020-11-05
$12.24M
derived: sum of 4 quarters · filed 2021-02-25
2019-06-30$3.20M
10-Q · filed 2020-11-05
$6.67M
derived: sum of 2 quarters · filed 2020-11-05
$10.42M
derived: sum of 3 quarters · filed 2021-02-25
$14.47M
derived: sum of 4 quarters · filed 2021-02-25
2019-03-31$3.48M
10-Q · filed 2020-11-05
$7.23M
derived: sum of 2 quarters · filed 2021-02-25
$11.27M
derived: sum of 3 quarters · filed 2021-02-25
$15.01M
derived: sum of 4 quarters · filed 2021-02-25
2018-12-31$3.75M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25
$7.79M
derived: sum of 2 quarters · filed 2021-02-25
$11.53M
derived: sum of 3 quarters · filed 2021-02-25
$16.20M
10-K · filed 2021-02-25
2018-09-30$4.04M
10-Q · filed 2019-11-06
$7.78M
derived: sum of 2 quarters · filed 2019-11-06
$12.45M
10-Q · filed 2018-11-06
$15.30M
derived: sum of 4 quarters · filed 2019-11-06
2018-06-30$3.74M
10-Q · filed 2019-11-06
$8.41M
10-Q · filed 2018-08-02
$11.26M
derived: sum of 3 quarters · filed 2019-11-06
$14.46M
derived: sum of 4 quarters · filed 2019-11-06
2018-03-31$4.67M
10-Q · filed 2019-11-06
$7.52M
derived: sum of 2 quarters · filed 2019-11-06
$10.72M
derived: sum of 3 quarters · filed 2019-11-06
2017-12-31$2.85M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27
$6.05M
derived: sum of 2 quarters · filed 2019-02-27
$10.80M
10-K · filed 2019-02-27
2017-09-30$3.20M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02
$7.96M
10-Q · filed 2017-11-02
2017-06-30$4.76M
10-Q · filed 2017-08-03
2016-12-31$8.82M
10-K · filed 2019-02-27
2016-06-30$2.47M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08
$4.54M
10-Q · filed 2016-08-08
2016-03-31$2.07M
10-Q · filed 2016-05-12
2015-12-31$3.57M
10-K · filed 2018-03-15
2015-06-30$7.08M
10-K · filed 2018-03-15
2014-06-30$332.00K
10-K · filed 2017-03-13
2013-06-30$178.00K
8-K · filed 2016-07-08